Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey

Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Diseas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2024-10, Vol.51 (10), p.1298-1309
Hauptverfasser: Okuse, Masanori, Soekawa, Masayuki, Itakura, Asako, Kawamura, Taisuke, Mburu, Sicily, Frade, Susan, Okubo, Yukari
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1309
container_issue 10
container_start_page 1298
container_title Journal of dermatology
container_volume 51
creator Okuse, Masanori
Soekawa, Masayuki
Itakura, Asako
Kawamura, Taisuke
Mburu, Sicily
Frade, Susan
Okubo, Yukari
description Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.
doi_str_mv 10.1111/1346-8138.17424
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11484140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3102471529</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3524-31e6a14ad10252c1e48338429a6b30c0a3fff9fdcfbf8c4824c9494fe4b1687c3</originalsourceid><addsrcrecordid>eNqFkctuEzEUhi0EomlhzQ5ZYsOCaX05k3jYIGhLoapExGVteTzH1NVkPNgzqbLrnleAl-uT4DQhAjZ4Y_n48yef8xPyhLNDntcRlzAtFJfqkM9AwD0y2VXukwmTqiwEsNke2U_pijFRlZw9JHuyEiVIzibk-xxj6tEOfomJBkfPTW86TEh7M3jshlzsaJ9C9PlsaeMTmnxbj7HB7iX9iGlsM-RiWNDbmx_zOzL5RE3X0De4Cl3z4vbmJx0ukZ61oTYtne9sJ1vbpzEucfWIPHCmTfh4ux-QL29PPx-_Ky4-nL0_fn1RWFkKKCTHqeFgGs5EKSxHUFIqEJWZ1pJZZqRzrnKNdbVTFpQAW0EFDqHmUzWz8oC82nj7sV5gY3OX0bS6j35h4koH4_XfN52_1F_DUnMOCjiwbHi-NcTwbcQ06IVPFts2jy6MSefRCpjxUlQZffYPehXG2OX-MsWFhBwcz9TRhrIxpBTR7X7DmV4nrde56nWu-i7p_OLpn03s-N_RZqDcANe-xdX_fPr85HQj_gUSYrbU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3112341741</pqid></control><display><type>article</type><title>Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey</title><source>MEDLINE</source><source>Wiley Blackwell Journals</source><creator>Okuse, Masanori ; Soekawa, Masayuki ; Itakura, Asako ; Kawamura, Taisuke ; Mburu, Sicily ; Frade, Susan ; Okubo, Yukari</creator><creatorcontrib>Okuse, Masanori ; Soekawa, Masayuki ; Itakura, Asako ; Kawamura, Taisuke ; Mburu, Sicily ; Frade, Susan ; Okubo, Yukari</creatorcontrib><description>Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.</description><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.17424</identifier><identifier>PMID: 39254310</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Arthritis, Psoriatic - diagnosis ; Arthritis, Psoriatic - epidemiology ; Arthritis, Psoriatic - psychology ; Arthritis, Psoriatic - therapy ; awareness ; comorbidities ; Comorbidity ; Cost of Illness ; Cross-Sectional Studies ; Decision making ; East Asian People ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Japan - epidemiology ; Joint diseases ; Male ; Middle Aged ; Original ; Patient Satisfaction ; Patients ; Psoriasis ; Psoriasis - epidemiology ; Psoriasis - psychology ; Psoriasis - therapy ; Psoriatic arthritis ; psoriatic disease ; Quality of Life ; Severity of Illness Index ; Skin diseases ; Social Stigma ; Surveys ; Surveys and Questionnaires ; treatment satisfaction</subject><ispartof>Journal of dermatology, 2024-10, Vol.51 (10), p.1298-1309</ispartof><rights>2024 The Author(s). published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Dermatological Association.</rights><rights>2024 The Author(s). The Journal of Dermatology published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Dermatological Association.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3524-31e6a14ad10252c1e48338429a6b30c0a3fff9fdcfbf8c4824c9494fe4b1687c3</cites><orcidid>0000-0002-9526-1259</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.17424$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.17424$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39254310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okuse, Masanori</creatorcontrib><creatorcontrib>Soekawa, Masayuki</creatorcontrib><creatorcontrib>Itakura, Asako</creatorcontrib><creatorcontrib>Kawamura, Taisuke</creatorcontrib><creatorcontrib>Mburu, Sicily</creatorcontrib><creatorcontrib>Frade, Susan</creatorcontrib><creatorcontrib>Okubo, Yukari</creatorcontrib><title>Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.</description><subject>Adult</subject><subject>Aged</subject><subject>Arthritis, Psoriatic - diagnosis</subject><subject>Arthritis, Psoriatic - epidemiology</subject><subject>Arthritis, Psoriatic - psychology</subject><subject>Arthritis, Psoriatic - therapy</subject><subject>awareness</subject><subject>comorbidities</subject><subject>Comorbidity</subject><subject>Cost of Illness</subject><subject>Cross-Sectional Studies</subject><subject>Decision making</subject><subject>East Asian People</subject><subject>Female</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Joint diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Patient Satisfaction</subject><subject>Patients</subject><subject>Psoriasis</subject><subject>Psoriasis - epidemiology</subject><subject>Psoriasis - psychology</subject><subject>Psoriasis - therapy</subject><subject>Psoriatic arthritis</subject><subject>psoriatic disease</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Skin diseases</subject><subject>Social Stigma</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><subject>treatment satisfaction</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNqFkctuEzEUhi0EomlhzQ5ZYsOCaX05k3jYIGhLoapExGVteTzH1NVkPNgzqbLrnleAl-uT4DQhAjZ4Y_n48yef8xPyhLNDntcRlzAtFJfqkM9AwD0y2VXukwmTqiwEsNke2U_pijFRlZw9JHuyEiVIzibk-xxj6tEOfomJBkfPTW86TEh7M3jshlzsaJ9C9PlsaeMTmnxbj7HB7iX9iGlsM-RiWNDbmx_zOzL5RE3X0De4Cl3z4vbmJx0ukZ61oTYtne9sJ1vbpzEucfWIPHCmTfh4ux-QL29PPx-_Ky4-nL0_fn1RWFkKKCTHqeFgGs5EKSxHUFIqEJWZ1pJZZqRzrnKNdbVTFpQAW0EFDqHmUzWz8oC82nj7sV5gY3OX0bS6j35h4koH4_XfN52_1F_DUnMOCjiwbHi-NcTwbcQ06IVPFts2jy6MSefRCpjxUlQZffYPehXG2OX-MsWFhBwcz9TRhrIxpBTR7X7DmV4nrde56nWu-i7p_OLpn03s-N_RZqDcANe-xdX_fPr85HQj_gUSYrbU</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Okuse, Masanori</creator><creator>Soekawa, Masayuki</creator><creator>Itakura, Asako</creator><creator>Kawamura, Taisuke</creator><creator>Mburu, Sicily</creator><creator>Frade, Susan</creator><creator>Okubo, Yukari</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9526-1259</orcidid></search><sort><creationdate>202410</creationdate><title>Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey</title><author>Okuse, Masanori ; Soekawa, Masayuki ; Itakura, Asako ; Kawamura, Taisuke ; Mburu, Sicily ; Frade, Susan ; Okubo, Yukari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3524-31e6a14ad10252c1e48338429a6b30c0a3fff9fdcfbf8c4824c9494fe4b1687c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Arthritis, Psoriatic - diagnosis</topic><topic>Arthritis, Psoriatic - epidemiology</topic><topic>Arthritis, Psoriatic - psychology</topic><topic>Arthritis, Psoriatic - therapy</topic><topic>awareness</topic><topic>comorbidities</topic><topic>Comorbidity</topic><topic>Cost of Illness</topic><topic>Cross-Sectional Studies</topic><topic>Decision making</topic><topic>East Asian People</topic><topic>Female</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Joint diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Patient Satisfaction</topic><topic>Patients</topic><topic>Psoriasis</topic><topic>Psoriasis - epidemiology</topic><topic>Psoriasis - psychology</topic><topic>Psoriasis - therapy</topic><topic>Psoriatic arthritis</topic><topic>psoriatic disease</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Skin diseases</topic><topic>Social Stigma</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><topic>treatment satisfaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okuse, Masanori</creatorcontrib><creatorcontrib>Soekawa, Masayuki</creatorcontrib><creatorcontrib>Itakura, Asako</creatorcontrib><creatorcontrib>Kawamura, Taisuke</creatorcontrib><creatorcontrib>Mburu, Sicily</creatorcontrib><creatorcontrib>Frade, Susan</creatorcontrib><creatorcontrib>Okubo, Yukari</creatorcontrib><collection>Wiley-Blackwell Open Access Titles(OpenAccess)</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okuse, Masanori</au><au>Soekawa, Masayuki</au><au>Itakura, Asako</au><au>Kawamura, Taisuke</au><au>Mburu, Sicily</au><au>Frade, Susan</au><au>Okubo, Yukari</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2024-10</date><risdate>2024</risdate><volume>51</volume><issue>10</issue><spage>1298</spage><epage>1309</epage><pages>1298-1309</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><abstract>Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional (HCP)‐diagnosed, moderate‐to‐severe plaque psoriasis, with or without PsA. Eligible patients who were recruited online completed a 25‐min internet‐based survey in Japanese. We assessed patients' understanding of the systemic nature of PsD, disease burden, perception towards their HCPs, treatment expectations, and satisfaction with care. Of the 148 patients, 74% were females. In total, 65% of patients were aware of the systemic nature of their disease. A minority of patients (27%) were aware that PsA was related to their psoriasis, and 30% and 42% of patients were unaware of any manifestations and comorbidities, respectively, related to PsD. Overall, 21% of patients reported that their disease has a “very large” to “extremely large” impact on their QOL (assessed by Dermatology Life Quality Index score), while the majority (61%) reported a “small” effect or “no effect” at all on QOL. Patients experienced stigma and discrimination and had a negative impact on relationships due to PsD. More patients with psoriasis and concomitant PsA (66%) were satisfied with their current treatment than those with psoriasis alone (46%). Overall, 41% of patients were not involved in deciding their treatment goals. These results suggest that Japanese patients may not be fully aware of the systemic nature of PsD, its manifestations and comorbidities. While these patients were somewhat satisfied with their current treatment, they were only occasionally consulted in deciding treatment goals. Policy measures are required to address the stigma and discrimination experienced by patients. Increased patient participation in their care supports shared decision‐making and enhanced treatment outcomes.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39254310</pmid><doi>10.1111/1346-8138.17424</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-9526-1259</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2024-10, Vol.51 (10), p.1298-1309
issn 0385-2407
1346-8138
1346-8138
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11484140
source MEDLINE; Wiley Blackwell Journals
subjects Adult
Aged
Arthritis, Psoriatic - diagnosis
Arthritis, Psoriatic - epidemiology
Arthritis, Psoriatic - psychology
Arthritis, Psoriatic - therapy
awareness
comorbidities
Comorbidity
Cost of Illness
Cross-Sectional Studies
Decision making
East Asian People
Female
Health Knowledge, Attitudes, Practice
Humans
Japan - epidemiology
Joint diseases
Male
Middle Aged
Original
Patient Satisfaction
Patients
Psoriasis
Psoriasis - epidemiology
Psoriasis - psychology
Psoriasis - therapy
Psoriatic arthritis
psoriatic disease
Quality of Life
Severity of Illness Index
Skin diseases
Social Stigma
Surveys
Surveys and Questionnaires
treatment satisfaction
title Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A23%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perspectives%20of%20Japanese%20patients%20on%20psoriatic%20disease%20burden:%20Results%20from%20%E2%80%9CPsoriasis%20and%20Beyond,%E2%80%9D%20the%20Global%20Psoriatic%20Disease%20Survey&rft.jtitle=Journal%20of%20dermatology&rft.au=Okuse,%20Masanori&rft.date=2024-10&rft.volume=51&rft.issue=10&rft.spage=1298&rft.epage=1309&rft.pages=1298-1309&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.17424&rft_dat=%3Cproquest_pubme%3E3102471529%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3112341741&rft_id=info:pmid/39254310&rfr_iscdi=true